Login / Signup

mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.

Eric KrochmalnekAndrea AccogliJudith St-OngeNassima Addour-BoudrahemGyan PrakashSung-Hoon KimTristan Brunette-ClementGhadd AlhajajLina MougharbelElena BruneauKenneth A MyersFrancois DubeauJason KaramchandaniJean-Pierre FarmerJeffrey AtkinsonJeffrey HallChantal Chantal PoulinBernard RosenblattJoel Lafond-LapalmeAlexander WeilCatherine Fallet-BiancoSteffen AlbrechtNahum SonenbergJean-Baptiste RiviereRoy W DudleyMyriam Srour
Published in: Neurology. Genetics (2023)
The AAF of somatic pathogenic variants correlated with the topographic distribution, histopathology, and postsurgical outcomes. Moreover, cortical regions with absent histologic FCD features had negligible or undetectable pathogenic variant loads. By contrast, specimens with frank histologic abnormalities had detectable pathogenic variant loads, which raises important questions as to whether there is a tolerable variant threshold and whether surgical margins should be clean, as performed in tumor resections. In addition, we describe 2 novel pathogenic variants, expanding the mTORopathy genetic spectrum. Although most pathogenic somatic variants are located at mutation hotspots, screening the full-coding gene sequence remains necessary in a subset of patients.
Keyphrases